(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione

C20H26N5O3S+ — CID 9238071

IUPAC(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione
SMILESCC[C@@]1(C)NC(=O)N(CC(=O)N2CC[NH+](Cc3nc4ccccc4s3)CC2)C1=O
InChIInChI=1S/C20H25N5O3S/c1-3-20(2)18(27)25(19(28)22-20)13-17(26)24-10-8-23(9-11-24)12-16-21-14-6-4-5-7-15(14)29-16/h4-7H,3,8-13H2,1-2H3,(H,22,28)/p+1/t20-/m1/s1
InChIKeyWUZOHVNEJIIXHQ-HXUWFJFHSA-O
MW416.53 g/mol
LogP0.24
Rot. Bonds5

About (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione

(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione (PubChem CID 9238071) has the molecular formula C20H26N5O3S+ and a molecular weight of 416.53 g/mol. Its IUPAC name is (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione
PubChem CID9238071
Molecular FormulaC20H26N5O3S+
Molecular Weight416.53 g/mol
Exact Mass416.18
IUPAC Name(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione
SMILESCC[C@@]1(C)NC(=O)N(CC(=O)N2CC[NH+](Cc3nc4ccccc4s3)CC2)C1=O
InChIInChI=1S/C20H25N5O3S/c1-3-20(2)18(27)25(19(28)22-20)13-17(26)24-10-8-23(9-11-24)12-16-21-14-6-4-5-7-15(14)29-16/h4-7H,3,8-13H2,1-2H3,(H,22,28)/p+1/t20-/m1/s1
InChIKeyWUZOHVNEJIIXHQ-HXUWFJFHSA-O
XLogP0.24
TPSA87.05 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500416.53
LogP ≤ 50.24
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione?
The IUPAC name of (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione (CID 9238071) is (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione.
What is the SMILES notation for (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione?
The canonical SMILES for (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione is CC[C@@]1(C)NC(=O)N(CC(=O)N2CC[NH+](Cc3nc4ccccc4s3)CC2)C1=O.
What is the InChIKey of (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione?
The InChIKey is WUZOHVNEJIIXHQ-HXUWFJFHSA-O. The full InChI is InChI=1S/C20H25N5O3S/c1-3-20(2)18(27)25(19(28)22-20)13-17(26)24-10-8-23(9-11-24)12-16-21-14-6-4-5-7-15(14)29-16/h4-7H,3,8-13H2,1-2H3,(H,22,28)/p+1/t20-/m1/s1.
What are the key properties of (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione?
(5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione has a molecular weight of 416.53 g/mol, XLogP of 0.24, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-3-[2-[4-(1,3-benzothiazol-2-ylmethyl)piperazin-4-ium-1-yl]-2-oxoethyl]-5-ethyl-5-methylimidazolidine-2,4-dione is sourced from PubChem (CID 9238071), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).